Tom ntej: 3-Methyl-7-(2-butyn-1-yl)-8-bromoxanthine CAS: 666816-98-4
Catalog Number | xwm 93622 |
Khoom npe | 3-Methyl-7-(2-butyn-1-yl)-8-bromoxanthine |
CAS | 666816-98-4 |
Molecular Formula | C10H9BrN4O2 |
Molecular Luj | 297.11 Nws |
Cov ntaub ntawv khaws cia | Ambient |
Khoom Specification
Qhov tshwm sim | Dawb hmoov |
Assay | 99% min |
3-Methyl-7-(2-butyn-1-yl)-8-bromoxanthine yog ib qho tshuaj lom neeg uas nyob hauv tsev neeg xanthine.Xanthine derivatives tau kawm ntau thiab paub txog lawv cov kev siv ntau yam, tshwj xeeb tshaj yog nyob rau hauv kev lag luam tshuaj.Ib daim ntawv thov tseem ceeb ntawm 3-Methyl-7-(2-butyn-1-yl)-8-bromoxanthine yog nws cov peev xwm siv tau. raws li cov tshuaj rau kev kho mob ntawm cov kab mob ua pa xws li mob hawb pob thiab mob ntsws obstructive pulmonary (COPD).Xanthine derivatives, suav nrog theophylline, tau ntev tau siv rau hauv cov tshuaj ua pa vim lawv cov bronchodilatory thiab tiv thaiv kev mob.Cov tebchaw no ua haujlwm los ntawm kev ua kom cov leeg du hauv cov hlab pas thiab txo qhov mob, yog li txhim kho kev ua pa.Qhov sib ntxiv ntawm bromine atom ntawm 8th txoj hauj lwm ntawm lub nplhaib xanthine hauv 3-Methyl-7-(2-butyn-1-yl) -8-bromoxanthine tuaj yeem txhim kho nws cov teebmeem bronchodilatory piv rau lwm yam xanthine derivatives.Bromine hloov pauv hauv cov sib xyaw zoo sib xws tau pom tias ua rau lawv muaj zog thiab lub sijhawm ua haujlwm.Yog li ntawd, cov tshuaj no yuav muaj peev xwm ua tau zoo dua thiab siv tau ntev dua bronchodilator rau cov mob ua pa. Tsis tas li ntawd, xanthines kuj tau tshawb xyuas rau lawv cov khoom muaj peev xwm neuroprotective.Lawv tau ua kom pom cov tshuaj tiv thaiv antioxidant thiab tiv thaiv kab mob, nrog rau lub peev xwm los txhim kho cerebral ntshav txaus thiab txhim kho kev txawj ntse.Cov khoom no ua rau lawv nthuav cov neeg sib tw rau cov kab mob neurodegenerative xws li Alzheimer's thiab Parkinson's cov kab mob. Ntxiv nrog rau cov kev siv tshuaj, 3-Methyl-7-(2-butyn-1-yl)-8-bromoxanthine kuj tuaj yeem pom siv hauv kev tshawb fawb tshawb fawb.Xanthine derivatives feem ntau yog siv los ua cov cuab yeej biochemical los kawm adenosine receptors thiab phosphodiesterase enzymes.Cov tebchaw no tuaj yeem ua raws li kev xaiv ligands lossis inhibitors, pab hauv kev tshawb xyuas ntawm cov txheej txheem molecular tshwj xeeb thiab txoj hauv kev.Qhov kev sib xyaw thiab kev hloov pauv ntawm 3-Methyl-7-(2-butyn-1-yl)-8-bromoxanthine tuaj yeem raug kho kom haum rau ntxiv. optimize nws cov khoom rau cov kev siv tshwj xeeb.Ntau yam tshuaj tiv thaiv, xws li kev hloov pauv, ntxiv, thiab kev sib txuas lus sib txuas, tuaj yeem ua haujlwm los qhia cov pab pawg ua haujlwm lossis hloov kho cov qauv tseem ceeb.Cov kev hloov kho no tuaj yeem txhim kho nws cov kev ua haujlwm pharmacological lossis pab txhawb kev txhim kho cov khoom siv nrog kev xaiv zoo dua thiab bioavailability.In xaus, 3-Methyl-7-(2-butyn-1-yl)-8-bromoxanthine tuav lub peev xwm tseem ceeb rau kev siv tshuaj ua pa. , neuroprotection, thiab kev tshawb fawb biochemical.Nws cov teebmeem bronchodilatory ua rau nws muaj kev vam meej rau kev kho mob ntawm cov kab mob ua pa, thiab nws cov khoom muaj peev xwm tiv thaiv neuroprotective qhia kev siv hauv cov kab mob neurodegenerative.Kev tshawb fawb ntxiv thiab kev txhim kho yuav tsim nyog los tshawb nrhiav thiab siv cov txiaj ntsig ntawm qhov sib xyaw no hauv ntau yam kev kho mob thiab kev tshawb fawb.